08.07.2011 • NewsKrkaPharmasales and profits

Slovenia's Krka Jan-June Sales Up 6% Year-On-Year

Slovenia's top pharmaceutical company Krka said on Thursday group sales rose 6% in the first half of 2011 compared with the same period last year to reach €528.8 million ($756.4 million).

In a statement after a shareholders' meeting, it said the biggest sales rise was recorded in Eastern Europe where sales jumped 12% to €134.6 million.
Krka also said it planned to list its shares on bourses outside Slovenia but gave no details.

The company also plans to continue buying its shares to up to 10% of total equity in the next three years to use them as currency for possible takeovers. At present Krka owns 5.2% of its shares.

 

Innovation Pitch

The Start-up Platform for Chemistry & Life Sciences
Discover Tomorrow’s Innovators

The Start-up Platform for Chemistry & Life Sciences

CHEManager Innovation Pitch supports innovation in the chemistry and life sciences start-up scene. The platform allows founders, young entrepreneurs, and start-ups to present their companies to the industry.

Interview

Specialty Chemicals in a Shifting World
Adapting to Tariffs and Strengthening Regional Networks

Specialty Chemicals in a Shifting World

Jennifer Abril, President & CEO of SOCMA, discusses the impact of new tariffs and the importance of regional supply networks in the specialty chemical industry.